{
    "2018-02-12": [
        [
            {
                "time": "2018-03-02",
                "original_text": "Is AbbVie or Vertex Pharmaceuticals the Better Buy Now?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Vertex Pharmaceuticals",
                        "Better Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-02",
                "original_text": "5 Solid Dividend Growth Stocks Amid Rising Rates",
                "features": {
                    "keywords": [
                        "Dividend Growth",
                        "Rising Rates"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-02",
                "original_text": "These 3 Drugs Are Critical to AbbVie's Success",
                "features": {
                    "keywords": [
                        "Drugs",
                        "Critical",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-02",
                "original_text": "AbbVie Showcases New, Late-Breaking Investigational Data at 2018 American Academy of Dermatology (AAD) Annual Meeting",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Investigational Data",
                        "AAD Meeting"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-02",
                "original_text": "These 3 Drugs Are Critical to AbbVie's Success",
                "features": {
                    "keywords": [
                        "Drugs",
                        "Critical",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-02",
                "original_text": "Is AbbVie Incâ€™s (NYSE:ABBV) ROE Of 93.77% Sustainable?",
                "features": {
                    "keywords": [
                        "ROE",
                        "Sustainable",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}